1,2,4‐Triazole‐3‐Thione Analogues with a 2‐Ethylbenzoic Acid at Position 4 as VIM‐type Metallo‐β‐Lactamase Inhibitors - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue ChemMedChem Année : 2022

1,2,4‐Triazole‐3‐Thione Analogues with a 2‐Ethylbenzoic Acid at Position 4 as VIM‐type Metallo‐β‐Lactamase Inhibitors

Georges Feller
  • Fonction : Auteur
Paola Sandra Mercuri
  • Fonction : Auteur
Moreno Galleni
  • Fonction : Auteur

Résumé

Metallo-β-lactamases (MBLs) are increasingly involved as a major mechanism of resistance to carbapenems in relevant opportunistic Gram-negative pathogens. Unfortunately, clinically efficient MBL inhibitors still represent an unmet medical need. We previously reported several series of compounds based on the 1,2,4-triazole-3-thione scaffold. In particular, Schiff bases formed between diversely 5-substituted-4-amino compounds and 2-carboxybenzaldehyde were broad-spectrum inhibitors of VIM-type, NDM-1 and IMP-1 MBLs. Unfortunately, these compounds were unable to restore antibiotic susceptibility of MBL-producing bacteria, probably because of poor penetration and/or susceptibility to hydrolysis. To improve their microbiological activity, we synthesized and characterized compounds where the hydrazone-like bond of the Schiff base analogues was replaced by a stable ethyl link. This small change resulted in a narrower inhibition spectrum, as all compounds were poorly or not inhibiting NDM-1 and IMP-1, but showed a significantly better activity on VIM-type enzymes, with K i values in the μM to sub-μM range. The resolution of the crystallographic structure of VIM-2 in complex with one of the best inhibitors yielded valuable information about their binding mode. Interestingly, several compounds were shown to restore the β-lactam susceptibility of VIM-type-producing E. coli laboratory strains and also of K. pneumoniae clinical isolates. In addition, selected compounds were found to be devoid of toxicity toward human cancer cells at high concentration, thus showing promising safety.
Fichier principal
Vignette du fichier
VerdirosaF_ChemMedChem2022.pdf (2.62 Mo) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

hal-03799357 , version 1 (05-10-2022)

Identifiants

Citer

Federica Verdirosa, Laurent Gavara, Laurent Sevaille, Giusy Tassone, Giuseppina Corsica, et al.. 1,2,4‐Triazole‐3‐Thione Analogues with a 2‐Ethylbenzoic Acid at Position 4 as VIM‐type Metallo‐β‐Lactamase Inhibitors. ChemMedChem, 2022, 17 (7), pp.e202100699. ⟨10.1002/cmdc.202100699⟩. ⟨hal-03799357⟩
82 Consultations
66 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More